跳至主要内容
临床试验/NCT07274800
NCT07274800已完成不适用

Adjuvant Ultra Hypofractionation Radiotherapy Versus Hypofractionation Radiotherapy in Treatment of Early Invasive Breast Cancer

Zagazig University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年11月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Acute Skin Toxicity (CTCAE v5.0)

研究概览

简要总结

breast-conserving surgery. One group receives ultra-hypofractionated radiotherapy (26 Gy in 5 sessions over 1 week), while the other group receives hypofractionated radiotherapy (40 Gy in 15 sessions over 3 weeks). The study aims to compare skin toxicity, cosmetic outcomes, and local cancer control between thetwo schedules . Participants are followed during and after radiotherapy for up to 24 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Histological diagnosis of breast adenocarcinoma
  • Prior breast conservative surgery negative resection margins (3 mm)
  • Pathological stage pT1-pT2, N0-1, pT3-N0, M0
  • No macroscopic evidence of distant metastases at diagnosis
  • Age 18-80 years
  • Female patients
  • Normal hematological and biochemical laboratory tests
  • Written informed consent was obtained from all patients

排除标准

  • Patients underwent mastectomy.
  • Locally advanced disease pT4, N2,
  • Positive surgical margins
  • Prior thoracic radiation
  • Synchronous second primary tumor
  • Distant metastases
  • Pregnancy
  • Presence of a concomitant psychiatric disorder precluding an aware informed consent.
  • Age >80 years
  • Low risk patient meeting all the following criteria (more than or equal 65 years, PT1, grade 1 or 2, +ER, -Her2nu, N0, M0).

结局指标

主要结局

Acute Skin Toxicity (CTCAE v5.0)

时间窗: From start of radiotherapy to 6 weeks post-treatment

Incidence and severity of acute skin toxicity (erythema, desquamation, edema) assessed

次要结局

  • Late Skin Toxicity and Cosmesis(12 months post-radiotherapy)
  • Locoregional Recurrence(Up to 24 months post-radiotherapy)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验